Toll Free: 1-888-928-9744

United States Cardiac Rhythm Management Devices Market Outlook to 2021

Published: Jan 22, 2016 | Pages: 119 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

United States Cardiac Rhythm Management Devices Market Outlook to 2021

Summary

GlobalData's new report, "United States Cardiac Rhythm Management Devices Market Outlook to 2021", provides key market data on the United States Cardiac Rhythm Management Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Cardiac Rhythm Management Devices market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Cardiac Rhythm Management Devices market.
- Global corporate-level profiles of key companies operating within the United States Cardiac Rhythm Management Devices market.
- Key players covered include Medtronic plc, St. Jude Medical, Inc., Boston Scientific Corporation, Biotronik SE & Co. KG and Others.

Reasons To Buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
 Table of Contents
1 Table of Contents 2 1.1 List of Tables 6 1.2 List of Figures 7 2 Introduction 8 2.1 What Is This Report About? 8 2.2 Cardiac Rhythm Management Devices Market Segmentation 8 2.3 Definitions of Markets Covered in the Report 9 3 Cardiac Rhythm Management Devices Market, United States 11 3.1 Cardiac Rhythm Management Devices Market, United States, Revenue ($m), 2007-2014 11 3.2 Cardiac Rhythm Management Devices Market, United States, Revenue ($m), 2014-2021 13 3.2.1 Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), by Segment, 2007-2014 15 3.2.2 Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), by Segment, 2007-2014 17 3.2.3 Pacemakers Market, United States, Revenue ($m), by Segment, 2007-2014 19 3.2.4 Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), by Segment, 2014-2021 21 3.2.5 Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), by Segment, 2014-2021 23 3.2.6 Pacemakers Market, United States, Revenue ($m), by Segment, 2014-2021 25 3.3 Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2007-2014 27 3.4 Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2014-2021 29 3.4.1 Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), by Segment, 2007-2014 31 3.4.2 Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), by Segment, 2007-2014 33 3.4.3 Pacemakers Market, United States, Volume (Units), by Segment, 2007-2014 35 3.4.4 Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), by Segment, 2014-2021 37 3.4.5 Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), by Segment, 2014-2021 39 3.4.6 Pacemakers Market, United States, Volume (Units), by Segment, 2014-2021 41 3.5 Cardiac Rhythm Management Devices Market, United States, Average Price ($), 2007-2021 43 3.6 Cardiac Rhythm Management Devices Market, United States, Distribution Share by Revenue ($m), 2013-2014 45 3.7 Cardiac Rhythm Management Devices Market, United States, Company Share by Revenue ($m), 2014 46 4 Overview of Key Companies in United States, Cardiac Rhythm Management Devices Market 48 4.1 Medtronic plc 48 4.1.1 Company Overview 48 4.2 St. Jude Medical, Inc. 48 4.2.1 Company Overview 48 4.3 Boston Scientific Corporation 48 4.3.1 Company Overview 48 4.4 Biotronik SE & Co. KG 49 4.4.1 Company Overview 49 5 Cardiac Rhythm Management Devices Market Pipeline Products 50 6 Financial Deals Landscape 51 6.1 Equity Offerings 51 6.1.1 Ventripoint Diagnostics to Raise up to USD0.3 Million in Private Placement of Units 51 6.1.2 Ventripoint Diagnostics Raises USD2.3 Million in Private Placement of Units 53 6.2 Venture Financing 55 6.2.1 EBR Systems Raises USD20 Million in Venture Financing 55 7 Recent Developments 57 7.1 Corporate Communications 57 7.1.1 Dec 22, 2015: SurModics Announces Device Veteran Shawn McCormick Joins Board of Directors 57 7.1.2 Nov 17, 2015: Proteus Digital Health Announces New Chairman of the Board and Chief Commercial Officer 57 7.1.3 Nov 16, 2015: Konica Minolta to Start In Vitro Diagnostics Business in European and American Markets: SPFS Immunoassay System on Reference Exhibit at MEDICA 2015 in Germany 58 7.1.4 Nov 04, 2015: Ventripoint Announces New Director and Provides Corporate Update 59 7.1.5 Oct 20, 2015: Cardiac Science Files Chapter 11 Petition to Facilitate Debt Restructuring 60 7.1.6 Oct 12, 2015: Orthopaedic Associates of Wisconsin and Blue Belt Technologies Announce First Surgery Center in Wisconsin to Implement CT-Free Robotic Orthopedic Surgery 61 7.1.7 Oct 09, 2015: Dako, an Agilent Technologies Company, Announces FDA Approval of New Test for Lung Cancer Patients 61 7.1.8 Aug 24, 2015: Daiichi Sankyo Obtains Approval in Japan for Supplementary Indication for "Artist Tablets" 62 7.1.9 Jul 21, 2015: iRhythm Technologies Appoints Marga Ortigas-Wedekind Executive Vice President, Global Marketing 63 7.1.10 Jul 02, 2015: BioTek Introduces Synergy Neo2 High Performance Multi-Mode Microplate Reader 64 7.1.11 Jun 25, 2015: Medtronic Names Geoff Martha Executive Vice President and President, Restorative Therapies Group 64 7.1.12 May 13, 2015: iRhythm Expands Leadership Team with Appointment of Derrick Sung, Ph.D. as Executive Vice President of Global Strategy and Corporate Development 65 7.1.13 May 04, 2015: Stereotaxis Elects Medical Device Industry Veteran Duane DeSisto to Board of Directors 66 7.1.14 Mar 25, 2015: Ventripoint Announces Resignation of Director 67 7.1.15 Mar 06, 2015: SurModics Announces New Board Chair 67 7.1.16 Feb 05, 2015: SurModics Announces Gerald B. Fischer's Retirement from Board of Directors 67 7.2 Financial Announcements 68 7.2.1 Dec 18, 2015: BRILIQUE (ticagrelor) receives positive European Union CHMP opinion for extended treatment of patients with a history of heart attack 68 7.2.2 Dec 18, 2015: Sarepta Therapeutics Announces FDA Advisory Committee Meeting to Review Eteplirsen as a Treatment for Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping 70 7.2.3 Nov 10, 2015: SurModics Reports Fourth Quarter Fiscal 2015 Results 71 7.2.4 Nov 03, 2015: Orthofix International Reports Third Quarter 2015 Financial Results 72 7.2.5 Oct 22, 2015: Bard Announces Third Quarter Results 74 7.2.6 Oct 01, 2015: Over 2000 Patients Treated with Ellipse Technologies' MAGEC System 74 7.2.7 Sep 30, 2015: MediWound Awarded BARDA Contract Valued Up to $112 Million for Development and Procurement of NexoBrid for the U.S. 77 7.2.8 Aug 20, 2015: New type of trial shows promise for several cancers 78 7.2.9 Aug 05, 2015: SurModics Reports Third Quarter Fiscal 2015 Results 81 7.2.10 Aug 04, 2015: Stereotaxis Reports 2015 Second Quarter Financial Results 82 7.2.11 Jul 23, 2015: Bard Announces Second Quarter Results 84 7.2.12 Jun 02, 2015: Medtronic Reports Fourth Quarter and Fiscal Year 2015 Financial Results 84 7.2.13 May 19, 2015: Medtronic Announces Preliminary Fourth Quarter and Fiscal Year 2015 Revenue Results 87 7.2.14 May 06, 2015: Stereotaxis Reports 2015 First Quarter Financial Results 90 7.2.15 Apr 30, 2015: SurModics Reports Second Quarter Fiscal 2015 Results 92 7.2.16 Apr 23, 2015: Bard Announces First Quarter Results 93 7.2.17 Apr 17, 2015: Bionomics Showcases BNC101 Oncology Drug Development Program at 2015 AACR Annual Meeting 93 7.2.18 Mar 11, 2015: The Medicines Company Provides new data on MDCO-216 at 2015 American College of Cardiology Scientific Sessions in San Diego 94 7.2.19 Feb 25, 2015: Stereotaxis Reports 2014 Fourth Quarter and Full Year Financial Results 95 7.2.20 Jan 29, 2015: SurModics Reports First Quarter Fiscal 2015 Results 97 7.2.21 Jan 29, 2015: Bard Announces Fourth Quarter Results 98 7.2.22 Jan 13, 2015: European Medicines Agency Grants Positive Opinion for Orphan Drug Status for Ovarian Cancer Oncolytic Vaccine 99 7.3 Government and Public Interest 100 7.3.1 Jul 14, 2015: Malaysia, The Hub Of Medical Device Manufacturing In Asean 100 7.4 Legal And Regulatory 101 7.4.1 Jan 05, 2016: LivaNova Provides Update on FDA Warning Letter 101 7.4.2 Nov 20, 2015: Medtronic Statement on U.S. Department of Treasury's Notice 2015-79 102 7.4.3 Jul 21, 2015: FDA Issues Warning Letter To C. R. Bard 102 7.4.4 Apr 02, 2015: Medtronic To Pay $4.41 Million To Resolve Allegations That It Unlawfully Sold Medical Devices Manufactured Overseas 103 7.4.5 Feb 06, 2015: Medtronic to Pay $2.8 Million to Resolve False Claims Act Allegations Related to "SubQ Stimulation" Procedures 104 7.4.6 Jan 13, 2015: Ventripoint Announces Completion of Initial Establishment Inspection by FDA 104 7.5 Other Significant Developments 105 7.5.1 Nov 18, 2015: iRhythm Technologies Launches New iOS App Enabling Patients to Report Irregular Heartbeat Symptoms for Physician Diagnosis 105 7.5.2 Mar 30, 2015: Ventripoint Announces Distribution Partner for Military and VA Medical Centers 106 7.5.3 Feb 19, 2015: Helius Medical Enrols First Patients In Multiple Sclerosis Feasibility Trial Of PoNS Device 106 7.5.4 Jan 12, 2015: Medtronic Awards $150,000 Locally in Health Access Grants 107 7.6 Product News 108 7.6.1 Dec 22, 2015: FDA Approves BIOTRONIK Iperia ICD Systems with Full-Body ProMRI Technology 108 7.6.2 Jan 26, 2015: SCS Introduces the Precisioncoat V Conformal Coating System 109 7.7 Strategy And Business Planning 109 7.7.1 Mar 30, 2015: Stereotaxis Extends Silicon Valley Bank Credit Facility by Three Years 109 8 Appendix 111 8.1 Research Methodology 112 8.1.1 Coverage 112 8.1.2 Secondary Research 112 8.1.3 Primary Research 113 8.1.4 Market Modeling and Forecasting 114 8.1.5 Company Share Analysis 117 8.1.6 Distribution Share Analysis 118 8.2 Expert Panel 119 8.3 GlobalData Consulting 119 8.4 Contact Us 119 8.5 Disclaimer 119
List of Tables
Table 1: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 12 Table 2: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 14 Table 3: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 16 Table 4: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 18 Table 5: Pacemakers Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 20 Table 6: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 22 Table 7: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 24 Table 8: Pacemakers Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 26 Table 9: Cardiac Rhythm Management Devices Market, United States, Volume (Units), Historic, 2007-2014 28 Table 10: Cardiac Rhythm Management Devices Market, United States, Volume (Units), Forecast, 2014-2021 30 Table 11: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), Historic, 2007-2014 32 Table 12: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), Historic, 2007-2014 34 Table 13: Pacemakers Market, United States, Volume (Units), Historic, 2007-2014 36 Table 14: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), Forecast, 2014-2021 38 Table 15: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), Forecast, 2014-2021 40 Table 16: Pacemakers Market, United States, Volume (Units), Forecast, 2014-2021 42 Table 17: Cardiac Rhythm Management Devices Market, United States, Average Price ($) Historic, 2007-2014 43 Table 18: Cardiac Rhythm Management Devices Market, United States, Average Price ($), Forecast, 2014-2021 44 Table 19: Cardiac Rhythm Management Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014 45 Table 20: Cardiac Rhythm Management Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2014 47 Table 21: Cardiac Rhythm Management Devices Market Pipeline Products 50 Table 22: Ventripoint Diagnostics to Raise up to USD0.3 Million in Private Placement of Units 51 Table 23: Ventripoint Diagnostics Raises USD2.3 Million in Private Placement of Units 53 Table 24: EBR Systems Raises USD20 Million in Venture Financing 55 Table 25: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country 114


List of Figures
Figure 1: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 11 Figure 2: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 13 Figure 3: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 15 Figure 4: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 17 Figure 5: Pacemakers Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 19 Figure 6: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 21 Figure 7: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 23 Figure 8: Pacemakers Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 25 Figure 9: Cardiac Rhythm Management Devices Market, United States, Volume (Units), Historic, 2007-2014 27 Figure 10: Cardiac Rhythm Management Devices Market, United States, Volume (Units), Forecast, 2014-2021 29 Figure 11: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), Historic, 2007-2014 31 Figure 12: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), Historic, 2007-2014 33 Figure 13: Pacemakers Market, United States, Volume (Units), Historic, 2007-2014 35 Figure 14: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), Forecast, 2014-2021 37 Figure 15: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), Forecast, 2014-2021 39 Figure 16: Pacemakers Market, United States, Volume (Units), Forecast, 2014-2021 41 Figure 17: Cardiac Rhythm Management Devices Market, United States, Company Share (%) 2014 46 Figure 18: GlobalData Epidemiology-Based Forecasting Model 116 Figure 19: GlobalData Capital Equipment-Based Forecasting Model 117 Figure 20: Primary Interviews by Participant Type (%) 118

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global automotive coatings market size is likely to be valued at USD 27.7 billion by 2022; as per a new research report by Radiant Insights, Inc. Vehicle aesthetics, UV radiation and temperature variation protection and enhance durability are certain

Read More...

Global animal feed additives market size was estimated at USD 16 billion in 2014. Growing meat consumption as a key protein source, especially in Asia Pacific and Latin America is expected to be a key driver for market demand over the forecast period

Read More...

Global gold nanoparticles market size is expected to reach 4.99 billion by 2020, witnessing gains at a CAGR of 24.7%. Positive outlook towards the increasing applications of nanotechnology in medical and dentistry such as drug delivery systems, nanom

Read More...

Global air traffic control equipment market is projected to reach USD 4.2 billion by 2020, as per a new research report by Radiant Insights, Inc. Mounting price sensitivity among customers with introduction of low fare airlines is expected to drive t

Read More...

Global agricultural films market size is anticipated to reach USD 10.5 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing need to raise agricultural productivity, in order to meet surplus demand by growing population i

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify